Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron submits request for EUA for COVID-19 antibody cocktail
Biopharma Reporter
Thu, 10/8/20 - 11:12 am
Regeneron
antibodies
COVID-19
Donald Trump
Emergency Use Authorization
Trump Touts Regeneron in Video Message
TheStreet.com
Wed, 10/7/20 - 11:28 pm
Regeneron
Donald Trump
politics
antibodies
COVID-19
Regeneron execs go on a whirlwind media tour after Trump takes COVID-19 antibody cocktail
Fierce Pharma
Wed, 10/7/20 - 10:56 am
Regeneron
COVID-19
Donald Trump
antibody cocktail
Regeneron CEO Says Trump Receiving Experimental Antibody Treatment Creates ‘Very Tough Situation’
Forbes
Mon, 10/5/20 - 11:47 pm
Regeneron
Donald Trump
COVID-19
Pharma CEOs
Leonard Schleifer
Regeneron Shares Jump On FDA Hopes After Trump Receives Its Experimental COVID-19 Treatment
TheStreet.com
Mon, 10/5/20 - 10:54 am
Regeneron
Emergency Use Authorization
FDA
COVID-19
Donald Trump
Go or no go? Vaccine panel upstages US approval decisions
EP Vantage
Fri, 10/2/20 - 12:44 pm
FDA
vaccines
COVID-19
advisory panel
Eysuvis
Brilinta
Kala Pharmaceuticals
dry eye disease
Regeneron
AstraZeneca
stroke
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Regeneron says antibody drug may speed recovery of patients with mild COVID-19
BioPharma Dive
Tue, 09/29/20 - 11:32 pm
Regeneron
antibodies
COVID-19
ESMO: Regeneron and Sanofi gun for Libtayo in first-line NSCLC with fresh survival stats
Fierce Pharma
Mon, 09/21/20 - 10:57 am
Libtayo
ESMO
Regeneron
Sanofi
non-small cell lung cancer
Sanofi/Regeneron’s Libtayo set for new skin cancer use
Pharmaforum
Fri, 09/18/20 - 10:40 am
Sanofi
Regeneron
Libtayo
clinical trials
skin cancer
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Mon, 09/14/20 - 10:50 am
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
Novartis says Beovu matched rival Eylea in visual acuity in eye disease
Pharma Live
Mon, 09/14/20 - 10:41 am
Novartis
Beovu
Eylea
Regeneron
diabetic macular edema
clinical trials
Sanofi Halts Kevzara Tests for Covid as Drug Fails to Help
Bloomberg
Tue, 09/1/20 - 10:41 am
Sanofi
Regeneron
Kevzara
COVID-19
clinical trials
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail
Pharmaforum
Tue, 08/25/20 - 10:18 am
AstraZeneca
Regeneron
antibody cocktail
clinical trials
COVID-19
Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Endpoints
Wed, 08/19/20 - 11:45 pm
Regeneron
inclisiran
RNAi
Novartis
New England Journal of Medicine
Regeneron, Roche team up in global deal on Covid-19 antibody cocktail
MedCity News
Wed, 08/19/20 - 11:13 am
Roche
Regeneron
COVID-19
antibodies
antibody cocktail
Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
Fierce Biotech
Wed, 08/12/20 - 10:53 am
Regeneron
evicanumab
FDA
Homozygous Familial Hypercholesterolemia
Regeneron profit beats, expects early results from COVID-19 trials in September
Yahoo/Reuters
Wed, 08/5/20 - 10:25 am
Regeneron
earnings
COVID-19
Regeneron says antibody cocktail prevents and treats coronavirus in animals
CNBC
Tue, 08/4/20 - 01:13 pm
Regeneron
antibodies
COVID-19
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »